Omacor patents are valid until 2020, Kuhnil says

Published: 2012-07-31 06:56:00

Updated: 2012-07-31 06:56:00

Kuhnil Pharmaceutical has recently confirmed that the Korean patents for Omacor (omega-3-acid ethyl esters), which has been also sold under the brand name of Lovaza in the U.S., are valid until February 2020 as an U.S. Delaware court ruled in favor of a Norwegian company Pronova BioPharma (uphold...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK